Michal Katzir

619 total citations
16 papers, 330 citations indexed

About

Michal Katzir is a scholar working on Epidemiology, Infectious Diseases and Virology. According to data from OpenAlex, Michal Katzir has authored 16 papers receiving a total of 330 indexed citations (citations by other indexed papers that have themselves been cited), including 10 papers in Epidemiology, 6 papers in Infectious Diseases and 3 papers in Virology. Recurrent topics in Michal Katzir's work include Pneumocystis jirovecii pneumonia detection and treatment (5 papers), HIV/AIDS drug development and treatment (5 papers) and Pneumonia and Respiratory Infections (4 papers). Michal Katzir is often cited by papers focused on Pneumocystis jirovecii pneumonia detection and treatment (5 papers), HIV/AIDS drug development and treatment (5 papers) and Pneumonia and Respiratory Infections (4 papers). Michal Katzir collaborates with scholars based in Israel, Canada and United States. Michal Katzir's co-authors include Michal Chowers, Pnina Shitrit, Galia Rahav, Yossi Paitan, Jacob Strahilevitz, Doron Boltin, Tal Brosh‐Nissimov, Gili Regev‐Yochay, Ori Elkayam and Ron Dagan and has published in prestigious journals such as PLoS ONE, Emerging infectious diseases and Vaccine.

In The Last Decade

Michal Katzir

15 papers receiving 321 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Michal Katzir Israel 12 149 125 63 54 54 16 330
Hitender Gautam India 13 187 1.3× 169 1.4× 42 0.7× 68 1.3× 46 0.9× 55 475
Rishma Amarsy France 10 154 1.0× 139 1.1× 46 0.7× 16 0.3× 30 0.6× 17 354
Taner Yıldırmak Türkiye 12 129 0.9× 231 1.8× 50 0.8× 30 0.6× 30 0.6× 45 404
Walid Khayr United States 9 105 0.7× 231 1.8× 104 1.7× 64 1.2× 25 0.5× 17 381
Serap Gençer Türkiye 11 137 0.9× 102 0.8× 30 0.5× 32 0.6× 31 0.6× 34 294
G. Orange United Kingdom 11 80 0.5× 60 0.5× 37 0.6× 36 0.7× 43 0.8× 15 251
Andrea Bedini Italy 14 221 1.5× 287 2.3× 38 0.6× 40 0.7× 18 0.3× 31 505
Frieder Pfäfflin Germany 9 90 0.6× 112 0.9× 16 0.3× 30 0.6× 18 0.3× 28 307
Haftom Legese Ethiopia 10 141 0.9× 119 1.0× 44 0.7× 41 0.8× 21 0.4× 20 356
Lázaro Vélez Colombia 14 288 1.9× 234 1.9× 51 0.8× 46 0.9× 25 0.5× 41 516

Countries citing papers authored by Michal Katzir

Since Specialization
Citations

This map shows the geographic impact of Michal Katzir's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Michal Katzir with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Michal Katzir more than expected).

Fields of papers citing papers by Michal Katzir

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Michal Katzir. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Michal Katzir. The network helps show where Michal Katzir may publish in the future.

Co-authorship network of co-authors of Michal Katzir

This figure shows the co-authorship network connecting the top 25 collaborators of Michal Katzir. A scholar is included among the top collaborators of Michal Katzir based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Michal Katzir. Michal Katzir is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

16 of 16 papers shown
1.
Gefen, Tal, Michal Katzir, Yaël C. Cohen, et al.. (2022). Microbiome Characterization of Infected Diabetic Foot Ulcers in Association With Clinical Outcomes: Traditional Cultures Versus Molecular Sequencing Methods. Frontiers in Cellular and Infection Microbiology. 12. 836699–836699. 25 indexed citations
2.
Paitan, Yossi, et al.. (2021). Characteristics of pelvic inflammatory disease caused by sexually transmitted disease – An epidemiologic study. Journal of Gynecology Obstetrics and Human Reproduction. 50(9). 102176–102176. 11 indexed citations
3.
Ben‐Ami, Ronen, Galia Rahav, Danny Alon, et al.. (2021). Healthcare-associated Pneumocystis jirovecii Pneumonia (PJP) Infection in HIV-negative Adults: a Multicenter Study.. PubMed. 23(5). 312–317. 1 indexed citations
4.
Katzir, Michal, et al.. (2021). Improving urinary tract infection treatment through a multifaceted antimicrobial stewardship intervention in the emergency department. The American Journal of Emergency Medicine. 49. 10–13. 9 indexed citations
5.
Ben‐Ami, Ronen, Galia Rahav, Danny Alon, et al.. (2020). Rituximab identified as an independent risk factor for severe PJP: A case-control study. PLoS ONE. 15(9). e0239042–e0239042. 18 indexed citations
6.
Shitrit, Pnina, et al.. (2018). Antibiotic Exposure in the Community and Resistance Patterns of Escherichia coli Community-Acquired Bloodstream Infection.. PubMed. 20(6). 382–384. 2 indexed citations
7.
Regev‐Yochay, Gili, Michal Katzir, Yonit Wiener‐Well, et al.. (2018). Pneumococcal Meningitis in Adults after Introduction of PCV7 and PCV13, Israel, July 2009–June 20151. Emerging infectious diseases. 24(7). 1275–1284. 19 indexed citations
8.
Regev‐Yochay, Gili, Michal Katzir, Jacob Strahilevitz, et al.. (2017). The herd effects of infant PCV7/PCV13 sequential implementation on adult invasive pneumococcal disease, six years post implementation; a nationwide study in Israel. Vaccine. 35(18). 2449–2456. 37 indexed citations
9.
Regev‐Yochay, Gili, Galia Rahav, Jacob Strahilevitz, et al.. (2013). A nationwide surveillance of invasive pneumococcal disease in adults in Israel before an expected effect of PCV7. Vaccine. 31(19). 2387–2394. 11 indexed citations
10.
Paitan, Yossi, et al.. (2013). Extended-spectrum beta-lactamase-producing Enterobacteriaceae carriage upon hospital admission: prevalence and risk factors. Journal of Hospital Infection. 85(3). 230–232. 25 indexed citations
11.
Turner, Dan, Sharon Amit, Osnat Penn, et al.. (2011). Emergence of an HIV‐1 cluster harbouring the major protease L90M mutation among treatment‐naïve patients in Tel Aviv, Israel. HIV Medicine. 13(4). 202–206. 7 indexed citations
12.
Paran, Yael, Doron Yablecovitch, Guy Choshen, et al.. (2009). C-reactive protein velocity to distinguish febrile bacterial infections from non-bacterial febrile illnesses in the emergency department. Critical Care. 13(2). R50–R50. 31 indexed citations
13.
Turner, Dan, Eduardo Shahar, Eugene Katchman, et al.. (2009). Prevalence of the K65R resistance reverse transcriptase mutation in different HIV‐1 subtypes in Israel. Journal of Medical Virology. 81(9). 1509–1512. 17 indexed citations
14.
Boltin, Doron, et al.. (2008). Corynebacterium striatum—A classic pathogen eluding diagnosis. European Journal of Internal Medicine. 20(3). e49–e52. 45 indexed citations
15.
Grossman, Zehava, Margalit Lorber, Pnina Shitrit, et al.. (2006). Comparative performance of the Amplicor HIV-1 monitor assay versus NucliSens EasyQ in HIV subtype C-infected patients. Journal of Medical Virology. 78(7). 883–887. 25 indexed citations
16.
Shitrit, Pnina, et al.. (2006). Active Surveillance for Methicillin-Resistant Staphylococcus aureus(MRSA) Decreases the Incidence of MRSA Bacteremia. Infection Control and Hospital Epidemiology. 27(10). 1004–1008. 47 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026